
John M. Jakicic, PhD
@jmjakicic
ID: 2181413926
15-11-2013 01:34:06
1,1K Tweet
579 Followers
260 Following

Really fun comparison of the calorie 🔥 from diff activities from John M. Jakicic, PhD . Always more with aerobic! #OW2022



News on our new T32 designed to train pre-doctoral students on translational obesity and metabolism research here KU Medical Center kumc.edu/about/news/new…

Excited to be starting up this study in Lawrence, KS. Please share with anyone who may be interested. BONUS we’re kicking off a separate support group intervention for caregivers at the same time! Lauren Ptomey (Silent P) Amy Bodde, PhD


Honored to have been quoted in the The Washington Post in a story by Geoffrey A. Fowler and to recently move my research program to KU Medical Center to continue the important work in obesity prevention and treatment and to focus on enhancing health and quality of life across the lifespan.



Thank you CU Endocrinology for inviting me.

Behavioral Markers of Diabetes Self-Management: State of the Science and Measurement Controversies — Soohyun Nam, PhD, APRN, ANP-BC, FAHA, FAAN; Carla K. Miller, PhD, RD; @sarahjaser2 and John M. Jakicic, PhD presented at #ADA2023. Recap in ADA Meeting News: bit.ly/3NNahPl


Bimagrumab heads to Indianapolis #obesity LillyDiabetes investor.lilly.com/news-releases/…

Time to get the best and legally covered exercise professionals in these weight loss clinics to prescribe safe and effective exercise for what will be a large (and growing) proportion of obese persons! tag Michael Joyner American College of Sports Medicine Canadian Society for Exercise Physiology A quote from a recent ACSM Bulletin by

Upcoming webinar: John M. Jakicic, PhD will discuss advancements in anti-obesity medications and their effects on body weight & body comp, as well as the role of physical activity within the context of these treatments. 📅 Jan. 18 🕛 noon EST Register: brnw.ch/21wFZXQ


Upcoming webinar: John M. Jakicic, PhD will discuss advancements in anti-obesity medications and their effects on body weight & body comp, as well as the role of physical activity within the context of these treatments. 📅 Jan. 18 🕛 noon EST Register: brnw.ch/21wG5LJ


A fully packed house to hear Dr Robert Kushner John M. Jakicic, PhD and Renee J. Rogers, PhD discuss contemporary anti-obesity medications and the role of the exercise professional in this morning’s #HFS24 keynote.


Read #ObesityJournal perspective "Physical activity in the new era of antiobesity medications" John M. Jakicic, PhD et al onlinelibrary.wiley.com/doi/10.1002/ob…

This perspective from John M. Jakicic, PhD Renee J. Rogers, PhD & Caroline Apovian MD highlights considerations for #fitnesspros, #researchers & #clinicians to consider related #physicalactivity & #exercise with contemporary anti-obesity #medications. Link: brnw.ch/21wHWZv


Reflecting on great moment from #ACSM24 sharing the stage with Drs. Caroline Apovian MD & John M. Jakicic, PhD to discuss the role of exercise for patients taking contemporary #obesity meds. Covering everything from #medicalmanagement to #bodycomposition and #biobehavioral ExRx considerations.


I am enormously proud today to announce the publication of the new ACSM Consensus Statement on Physical Activity for Adults with Excess Body Weight and Adiposity. Thank you to John M. Jakicic, PhD for his leadership, to American College of Sports Medicine for the support, to Translational Journal of the ACSM for the platform, and the


🚨New American College of Sports Medicine Consensus Statement🚨 Physical Activity and Excess Body Weight and Adiposity for Adults. American College of Sports Medicine Consensus Statement John M. Jakicic, PhD et al. 🔗👉 brnw.ch/21wMWzK #RealWorldApplication

